Beijing Tiantan Biological Products Corp. Ltd. (600161) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beijing Tiantan Biological Products Corp. Ltd.

Why is Beijing Tiantan Biological Products Corp. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 14.10% and Operating profit at 18.18% over the last 5 years

INTEREST(9M) At CNY 3.71 MM has Grown at 45.41%
OPERATING CASH FLOW(Y) Lowest at CNY -688.6 MM
NET PROFIT(HY) At CNY 539.42 MM has Grown at -25.71%

Below par performance in long term as well as near term

Along with generating -20.49% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Tiantan Biological Products Corp. Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Beijing Tiantan Biological Products Corp. Ltd.

-20.49%

-1.72

20.10%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

14.10%

EBIT Growth (5y)

18.18%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.20

Sales to Capital Employed (avg)

0.52

Tax Ratio

17.23%

Dividend Payout Ratio

12.76%

Pledged Shares

Institutional Holding

ROCE (avg)

28.16%

ROE (avg)

16.39%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.26

EV to EBIT

15.74

EV to EBITDA

13.31

EV to Capital Employed

3.69

EV to Sales

5.72

PEG Ratio

Dividend Yield

0.44%

ROCE (Latest)

23.46%

ROE (Latest)

17.22%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET SALES(9M)

At CNY 5,036.29 MM has Grown at 27.15%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

-15What is not working for the Company

INTEREST(9M)

At CNY 3.71 MM has Grown at 45.41%

OPERATING CASH FLOW(Y)

Lowest at CNY -688.6 MM

NET PROFIT(HY)

At CNY 539.42 MM has Grown at -25.71%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0%

RAW MATERIAL COST(Y)

Grown by 101.9% (YoY

CASH AND EQV(HY)

Lowest at CNY 2,280.72 MM

DEBT-EQUITY RATIO (HY)

Highest at 0 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 0%

EPS(Q)

Lowest at CNY 0

Here's what is working for Beijing Tiantan Biological Products Corp. Ltd.

Net Sales

At CNY 1,792.63 MM has Grown at 18.21%

over average net sales of the previous four periods of CNY 1,516.45 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Here's what is not working for Beijing Tiantan Biological Products Corp. Ltd.

Interest

At CNY 3.71 MM has Grown at 45.41%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 539.42 MM has Grown at -25.71%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 0% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Cash Flow

Lowest at CNY -688.6 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

EPS

Lowest at CNY 0

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Cash and Eqv

Lowest at CNY 2,280.72 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 0 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 0%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 101.9% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales